Blockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Immunology

• Publication date

  2018-02-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.4049/jimmunol.1701752PMID 29445008PMCID PMC5860988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucose represses dendritic cell-induced T cell responses

  2017cited by this paper
• GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.

  2017cited by this paper
• β2‐AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells

  2017cited by this paper
• Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function

  2017cited by this paper
• STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

  2017cited by this paper
• β2-adrenoceptor signaling reduction in dendritic cells is involved in the inflammatory response in adjuvant-induced arthritic rats

  2016cited by this paper
• Norepinephrine Controls Effector T Cell Differentiation through β2-Adrenergic Receptor–Mediated Inhibition of NF-κB and AP-1 in Dendritic Cells

  2016cited by this paper
• Immunometabolism governs dendritic cell and macrophage function

  2016cited by this paper
• Sympathetic neural signaling via the β2‐adrenergic receptor suppresses T‐cell receptor‐mediated human and mouse CD8+ T‐cell effector function

  2016cited by this paper
• High Mitochondrial Respiration and Glycolytic Capacity Represent a Metabolic Phenotype of Human Tolerogenic Dendritic Cells

  2015cited by this paper
• Production of IL-10 by CD4+ regulatory T cells during the resolution of infection promotes the maturation of memory CD8+ T cells

  2015cited by this paper
• Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways.

  2015cited by this paper
• Granzyme B–Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease

  2015cited by this paper
• Housing Temperature–Induced Stress Is Suppressing Murine Graft-versus-Host Disease through β2-Adrenergic Receptor Signaling

  2015cited by this paper
• Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation

  2014cited by this paper
• Adrenergic β2 Receptor Activation Stimulates Anti-Inflammatory Properties of Dendritic Cells In Vitro

  2014cited by this paper
• Dendritic cell metabolism

  2014cited by this paper
• Host-derived CD8⁺ dendritic cells protect against acute graft-versus-host disease after experimental allogeneic bone marrow transplantation.

  2014cited by this paper
• Metabolic Control of Dendritic Cell Activation and Function: Recent Advances and Clinical Implications

  2014cited by this paper
• TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation

  2014cited by this paper
• Granzyme B–Mediated Damage of CD8+ T Cells Impairs Graft-versus-Tumor Effect

  2013cited by this paper
• STAT3 activation

  2013cited by this paper
• A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease

  2012cited by this paper
• Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

  2012cited by this paper
• Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis

  2011cited by this paper
• Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

  2011cited by this paper
• β2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response.

  2011cited by this paper
• Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

  2010cited by this paper
• Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation.

  2010cited by this paper
• Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease.

  2010cited by this paper
• Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function

  2010influential reference
• Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update.

  2010cited by this paper
• Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.

  2010cited by this paper
• Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

  2009cited by this paper
• Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.

  2009cited by this paper
• CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease

  2008cited by this paper
• The gp130/STAT3 signaling pathway mediates β‐adrenergic receptor‐induced atrial natriuretic factor expression in cardiomyocytes

  2008cited by this paper
• Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms.

  2007cited by this paper
• β2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-κB-independent mechanisms

  2007cited by this paper
• Stress System Activity, Innate and T Helper Cytokines, and Susceptibility to Immune‐Related Diseases

  2006cited by this paper
• Host Dendritic Cells Alone Are Sufficient to Initiate Acute Graft-versus-Host Disease1

  2004cited by this paper
• RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma.

  2004cited by this paper
• Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.

  2003cited by this paper
• B Cell Receptor- and β2-Adrenergic Receptor-Induced Regulation of B7-2 (CD86) Expression in B Cells1

  2002cited by this paper
• Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.

  2001cited by this paper
• Catecholamines in murine bone marrow derived mast cells.

  2001cited by this paper
• Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

  1999cited by this paper
• Neural and endogenous catecholamines in the bone marrow. Circadian association of norepinephrine with hematopoiesis?

  1998cited by this paper

• Neuroimmunometabolic co-evolution in the tumor micro- and macroenvironment.

  2026cites this paper
• Immune-Centered Cross-Talk Between Cancer Cells and the Tumor Microenvironment—Implications for Therapy

  2026cites this paper
• Cellular senescence in the innervated niche modulates cancer-associated pain: an emerging therapeutic target?

  2025cites this paper
• Dynamic Interplay of Neuroendocrine Signaling and Immuno-surveillance in Tumor Niche Remodeling.

  2025cites this paper
• A retrospective study on beta-blocker use and outcomes in hematopoietic stem cell transplant patients

  2025influential citation
• Peripheral nerves-cancer cross-talk: the next frontier in cancer treatment

  2025cites this paper
• Tumor microenvironment in osteosarcoma: From cellular mechanism to clinical therapy

  2025cites this paper
• The neuroscience in breast cancer: Current insights and clinical opportunities

  2025cites this paper
• Nerves at Play: The Peripheral Nervous System in Extracranial Malignancies.

  2025cites this paper
• Sympathetic nerve signaling rewires the tumor microenvironment: a shift in “microenvironmental-ity”

  2025cites this paper
• Targeting the pentose phosphate pathway mitigates graft-versus-host disease by rewiring alloreactive T cell metabolism

  2025cites this paper
• Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies

  2024cites this paper
• Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies

  2024cites this paper
• Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases

  2023cites this paper
• Chronic Adrenergic Stress and Generation of Myeloid-Derived Suppressor Cells: Implications for Cancer Immunotherapy in Dogs.

  2023cites this paper
• From the Inside Out: Exposing the Roles of Urea Cycle Enzymes in Tumors and Their Micro and Macro Environments.

  2023cites this paper
• Crosstalk between the peripheral nervous system and breast cancer influences tumor progression.

  2022cites this paper
• Murine precursors to type 1 conventional dendritic cells induce tumor cytotoxicity and exhibit activated PD-1/PD-L1 pathway

  2022cites this paper
• Effect of Cytomegalovirus on the Immune System: Implications for Aging and Mental Health.

  2022cites this paper
• Neuroendocrine Regulation of Stress‐Induced T Cell Dysfunction during Lung Cancer Immunosurveillance via the Kisspeptin/GPR54 Signaling Pathway

  2022cites this paper
• Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing mice.

  2021cites this paper
• MyD88 Costimulation in Donor CD8+ T Cells Enhances the Graft-versus-Tumor Effect in Murine Hematopoietic Cell Transplantation

  2021cites this paper
• β2-adrenergic receptor activation on donor cells ameliorates acute GvHD.

  2020cites this paper
• The updated landscape of tumor microenvironment and drug repurposing

  2020cites this paper
• Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation

  2020cites this paper
• Neural regulation of drug resistance in cancer treatment.

  2019cites this paper
• Destress and do not suppress: targeting adrenergic signaling in tumor immunosuppression.

  2019cites this paper
• b2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells

  2019cites this paper
• Beta-Adrenergic Signaling in Tumor Immunology and Immunotherapy.

  2019cites this paper
• β2 Adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells.

  2019cites this paper